PROK insider trading
NasdaqCM HealthcarePROKIDNEY CORP.: insider trade history from SEC Form 4 filings.
About PROKIDNEY CORP.
ProKidney Corp., a clinical-stage biotechnology company, develops a cell therapy platform for the treatment of multiple chronic kidney diseases in the United States. Its lead product candidate, rilparencel, includes autologous selected renal cells (SRC) in Phase 3 and Phase 2 clinical studies in subjects with moderate to severe chronic kidney disease and diabetes. The company also develops a cryopreserved version of rilparencel that allows for long-term product preservation to be used in Phase 2 and 3 trials of rilparencel. ProKidney Corp. was founded in 2015 and is headquartered in Winston-Salem, North Carolina.
Company website: prokidney.com
PROK insider activity at a glance
FilingIQ tracks 104 insider transactions for PROK in filings since Jul 13, 2022. The most recent transaction is dated Aug 20, 2026.
Across the full history, 18 open-market purchases
and 56 open-market sales
were filed under transaction codes P and S respectively. Compensatory share awards
(code A) and option exercises (code M) are tracked separately and not counted here.
The average FilingIQ composite score on PROK insider trades is 53.2/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.
Latest PROK Form 4 filings
Most recent disclosures. Sign up to filter by score, transaction code, or insider role.
Other Healthcare tickers with recent insider activity
Frequently asked
- How many insider trades does FilingIQ track for PROK?
- FilingIQ tracks 104 Form 4 insider transactions for PROK (PROKIDNEY CORP.), covering filings from Jul 13, 2022 onwards. 8 of those are dated within the last 90 days.
- Are PROK insiders net buyers or net sellers?
- Across the full Form 4 history for PROK, 18 transactions (17%) were open-market purchases and 56 (54%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
- Where does PROK insider data come from?
- Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ normalises insider identity across reporting variations and scores discretionary open-market purchases and sales on its multi-factor composite model.
- What sector is PROK in?
- PROKIDNEY CORP. (PROK) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $694.93M.
Methodology & sources
Every PROK insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.